Tillis, cleared to resume in-person activities, participating in COVID antibody study
Posted October 13, 2020 8:00 a.m. EDT
Updated October 13, 2020 1:53 p.m. EDT
Washington — U.S. Sen. Thom Tillis, who tested positive for coronavirus earlier this month, has been cleared to resume in-person activities, according to his doctor.
The senator will also take part in an antibody study to help experts learn more about COVID-19 and how it is spreading.
Hours after President Donald Trump was hospitalized with COVID-19 on Oct. 2, Tillis announced his own positive test.
Tillis shared that he tested positive but was experiencing few symptoms other than loss of taste and smell. After his diagnosis, Tillis said he regretted removing his face mask while attending an event in the White House.
According to Tillis’ personal physician, hes now meets the CDC's three guidelines for ending isolation, which include 10 days of quarantine after testing positive, being fever-free for at least 24 hours and showing no additional symptoms.
Tillis said he plans to return to Washington to participate in the confirmation hearings for Supreme Court nominee Judge Amy Coney Barrett. He released a statement saying, "I feel very fortunate that I had a mild case with few symptoms, and I want to thank North Carolinians for their prayers and well-wishes."
The antibody study Tillis will participate in is a partnership between Atrium Health and Wake Forest Baptist Health and funded through the CARES Act.
Tillis also plans to participate in a large study by the University of North Carolina at Chapel Hill to develop, validate, improve and implement serological testing and associated technologies in response to the pandemic.